Refactor Capital — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Modulo is a biotech company focused on the neuroimmune system, developing treatments for brain and central nervous system disorders.
AI & Machine LearningBiotechDeep TechLos Altos, US
Mike Horowitz(CEO & Co-founder)Justin Ichida(Co-founder)inScott Patterson(CTO & Co-founder)inJoe Wagner(Chief Development Officer)
BoardAlda Leu Dennis(Director)inNicholas Saccomano(Director)
Co-investorsCantos VenturesHAWKTAILSpacecadet VenturesBiovergeBuilders VCInitialized Capital
Orchid Hospital operates two healthcare facilities in Phnom Penh, Cambodia, providing specialized obstetrics, gynecology, pediatrics, maternity care, and general medical services.
HealthtechMedical DevicesPhnom Penh, KH
Co-investorsNavis Capital PartnersDay One VenturesIntel CapitalPebblebedTeam8
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.